You are here: Industry Insights > Generic

News List

FDA announces new data points to aid generic drug developers europeanpharmaceuticalreview
June 24, 2019
The FDA has released new data points which increase transparency for generic-drug competitors.
ANI Pharmaceuticals Expands Generic Pipeline contractpharma
June 19, 2019
Acquires seven development stage drug products from Coeptis.
US drugmakers allegedly collude on generic price hikes europeanpharmaceuticalreview
May 15, 2019
A coalition of 43 attorneys general allege generic drug manufacturers colluded, overcharging US states and consumers billions.
Teva and Other Generic Drugmakers Inflated Prices Up to 1,000%, State Prosecutors Say nytimes
May 13, 2019
Leading drug companies including Teva, Pfizer, Novartis and Mylan conspired to inflate the prices of generic drugs by as much as 1,000 percent, according to a far-reaching lawsuit filed on Friday by 44 states.
Teva launches generic version of VESIcare (solifenacin succinate) tablets in US pharmaceutical-business-review
April 24, 2019
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the launch of a generic version of VESIcare (solifenacin succinate) Tablets, 5 mg and 10 mg, in the U.S.
Cambrex Opens QC Lab in Italy contractpharma
April 24, 2019
Cambrex Corporation has opened a new 120 square meter quality control (QC) laboratory at its site in Paullo, Milan, Italy.
Teva launches generic AndroGel biospectrumasia
April 22, 2019
Testosterone Gel 1.62% CIII is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone
FDA Approves First Generic Naloxone Nasal Spray to Treat Opioid Overdose drugs
April 22, 2019
FDA Approves First Generic Naloxone Nasal Spray to Treat Opioid Overdose
J&J, under 'accelerating' generic and biosim attack…… fiercepharma
April 18, 2019
Johnson & Johnson's pharma business has been beating the market for years now, but that's about to change. A wave of ……
New generic valsartan approved to address shortages europeanpharmaceuticalreview
April 12, 2019
The FDA has prioritised the review of this drug application after multiple recalls of generic valsartan products from several manufacturers…

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page